Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Reprod Immunol ; 72(6): 527-33, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25112392

ABSTRACT

PROBLEM: The contribution of Pregnancy-specific glycoproteins (PSG), the major variant of PSG released into the circulation during pregnancy, to the pregnancy-dependent improvement of rheumatoid arthritis (RA) has still not been elucidated. METHOD OF STUDY: Collagen-induced arthritis (CIA) was used to test the hypothesis that PSG1a when released into circulation has a modulatory role on the Th1-pathogenic response, thus improving the CIA symptoms. In vivo expression of PSG1a was induced by injection of the vaccinia (Vac)-based expression vector harboring the complete open-reading frame of PSG1a cDNA. RESULTS: In vivo PSG1a expression during the induction of CIA ameliorated the clinical symptoms, thereby reducing the arthritis score and incidence. Significantly lower levels of IL-17, IL-6, and IFN-γ, but higher levels of TGF-ß and IL-10 were secreted by collagen type II-stimulated spleen mononuclear cells from Vac-PSG1a-treated mice compared with control mice. Moreover, Vac-PSG1a treatment promoted the increase in splenic CD4+CD25+Foxp3+ Treg cells. CONCLUSION: Pre-clinical Vac-PSG1a treatment suppressed the Th1- and Th17-type-specific responses, leading to an increase in splenic Treg cells as well as IL-10- and TGF-ß-secreting cells, with the CIA symptoms being ameliorated.


Subject(s)
Arthritis, Experimental/therapy , Immunomodulation , Pregnancy-Specific beta 1-Glycoproteins/immunology , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Animals , CD4 Antigens/metabolism , Cells, Cultured , Cytokines/metabolism , Forkhead Transcription Factors/metabolism , Genetic Vectors/genetics , Humans , Interleukin-2 Receptor alpha Subunit/metabolism , Male , Mice , Mice, Inbred DBA , Pregnancy-Specific beta 1-Glycoproteins/genetics , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Vaccinia virus
2.
PLoS One ; 7(7): e40356, 2012.
Article in English | MEDLINE | ID: mdl-22848374

ABSTRACT

Dendritic cells (DC) have the potential to control the outcome of autoimmunity by modulating the immune response. In this study, we tested the ability of Fasciola hepatica total extract (TE) to induce tolerogenic properties in CpG-ODN (CpG) maturated DC, to then evaluate the therapeutic potential of these cells to diminish the inflammatory response in collagen induced arthritis (CIA). DBA/1J mice were injected with TE plus CpG treated DC (T/C-DC) pulsed with bovine collagen II (CII) between two immunizations with CII and clinical scores CIA were determined. The levels of CII-specific IgG2 and IgG1 in sera, the histological analyses in the joints, the cytokine profile in the draining lymph node (DLN) cells and in the joints, and the number, and functionality of CD4+CD25+Foxp3+ T cells (Treg) were evaluated. Vaccination of mice with CII pulsed T/C-DC diminished the severity and incidence of CIA symptoms and the production of the inflammatory cytokine, while induced the production of anti-inflammatory cytokines. The therapeutic effect was mediated by Treg cells, since the adoptive transfer of CD4+CD25+ T cells, inhibited the inflammatory symptoms in CIA. The in vitro blockage of TGF-ß in cultures of DLN cells plus CII pulsed T/C-DC inhibited the expansion of Treg cells. Vaccination with CII pulsed T/C-DC seems to be a very efficient approach to diminish exacerbated immune response in CIA, by inducing the development of Treg cells, and it is therefore an interesting candidate for a cell-based therapy for rheumatoid arthritis (RA).


Subject(s)
Adjuvants, Immunologic/pharmacology , Antigens, Helminth/pharmacology , Arthritis, Experimental/immunology , Dendritic Cells/immunology , Fasciola hepatica/chemistry , Forkhead Transcription Factors , Immune Tolerance/drug effects , Oligodeoxyribonucleotides/pharmacology , T-Lymphocytes, Regulatory/immunology , Animals , Antigens, Helminth/chemistry , Arthritis, Experimental/therapy , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/therapy , Cattle , Cell- and Tissue-Based Therapy , Immunization , Male , Mice , Transforming Growth Factor beta/immunology
3.
J Infect Dis ; 205(3): 506-14, 2012 Feb 01.
Article in English | MEDLINE | ID: mdl-21949043

ABSTRACT

Dendritic cells (DCs) can function as adjuvants able to mediate protection against different pathogens. Given that successful vaccination against Fasciola hepatica is mostly related to the induction of Th1 responses, we studied the potential of DCs loaded with F. hepatica antigens and lipopolysaccharide (LPS) (which promote DCs maturation) as a vaccine against fasciolosis in BALB/c mice. However, only a semimature phenotype was achieved when DCs were simultaneously cultured with an F. hepatica total extract (TE) and LPS. The activation status of TE-loaded DCs was enhanced when these cells were treated with TE 90 minutes before being stimulated with LPS (TE90 DCs). More importantly, a single vaccination of mice with TE90 DCs stimulated a systemic Th1 response and conferred protection against hepatic damage induced by F. hepatica infection. Thus, TE90 DCs may prove to be a useful new tool for vaccination against F. hepatica.


Subject(s)
Adoptive Transfer/methods , Antigens, Helminth/immunology , Dendritic Cells/immunology , Fasciola hepatica/immunology , Fascioliasis/prevention & control , Lipopolysaccharides/immunology , Vaccination/methods , Animals , Cytokines/metabolism , Disease Models, Animal , Fascioliasis/immunology , Fascioliasis/pathology , Female , Histocytochemistry , Liver/immunology , Liver/pathology , Mice , Mice, Inbred BALB C , Microscopy , Th1 Cells/immunology
4.
Vet Immunol Immunopathol ; 137(1-2): 36-46, 2010 Sep 15.
Article in English | MEDLINE | ID: mdl-20447697

ABSTRACT

Fasciola hepatica is a helminth trematode that migrates through the host tissues until reaching bile ducts where it becomes an adult. During its migration the parasite releases different excretory-secretory products (ESP), which are in contact with the immune system. In this study, we focused on the effect of ESP on the maturation and function of murine bone marrow derived-dendritic cells (DC). We found that the treatment of DC with ESP failed to induce a classical maturation of these cells, since ESP alone did not activate DC to produce any cytokines, although they impaired the ability of DC to be activated by TLR ligands and also their capacity to stimulate an allospecific response. In addition, using an in vitro ovalbumin peptide-restricted priming assay, ESP-treated DC exhibited a capacity to drive Th2 and regulatory T cell (Treg) polarization of CD4(+) cells from DO11.10 transgenic mice. This was characterized by increased IL-4, IL-5, IL-10 and TGF-beta production and the expansion of CD4(+)CD25(+)Foxp3(+) cells. Our results support the hypothesis that ESP from F. hepatica modulate the maturation and function of DC as part of a generalized immunosuppressive mechanism that involves a bias towards a Th2 response and Treg development.


Subject(s)
Dendritic Cells/immunology , Fasciola hepatica/immunology , Helminth Proteins/physiology , Immune Tolerance , Myeloid Cells/immunology , Animals , Cytokines/biosynthesis , Female , Forkhead Transcription Factors/analysis , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Myeloid Differentiation Factor 88/physiology , Th2 Cells/immunology , Toll-Like Receptors/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...